2-HYDROXYPROPYL PHENYL ARSINIC ACID

Suppliers

Names

[ CAS No. ]:
21905-32-8

[ Name ]:
2-HYDROXYPROPYL PHENYL ARSINIC ACID

[Synonym ]:
2-Hydroxypropyl phenyl arsinic acid

Chemical & Physical Properties

[ Boiling Point ]:
431.7ºC at 760 mmHg

[ Molecular Formula ]:
C9H13AsO3

[ Molecular Weight ]:
244.11900

[ Flash Point ]:
229ºC

[ Exact Mass ]:
244.00800

[ PSA ]:
57.53000

[ LogP ]:
0.13940

[ Vapour Pressure ]:
3.22E-08mmHg at 25°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CH7900000
CHEMICAL NAME :
Arsine oxide, hydroxy(2-hydroxypropyl)phenyl-
CAS REGISTRY NUMBER :
21905-32-8
LAST UPDATED :
199503
DATA ITEMS CITED :
5
MOLECULAR FORMULA :
C9-H13-As-O3
MOLECULAR WEIGHT :
244.14
WISWESSER LINE NOTATION :
Q3-AS-QO&R

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CSLNX* U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) Volume(issue)/page/year: NX#06914 *** U.S. STANDARDS AND REGULATIONS *** OSHA PEL (Gen Indu):8H TWA 0.5 mg(As)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Construc):8H TWA 0.5 mg(As)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):8H TWA 0.5 mg(As)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 OSHA PEL (Fed Cont):8H TWA 0.5 mg(As)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 41,50-204.50,1994

Related Compounds

  • (o-Chlorophenyl)[3-(2,4-dichlorophenoxy)-2-hydroxypropyl]arsinic acid
  • 2-Propanol,1-[(m-chlorophenyl)hydroxyarsino]-, As-oxide (8CI)
  • 2-Propanol,1-[(o-chlorophenyl)hydroxyarsino]-, As-oxide (8CI)
  • 2-Propanol,1-[(p-chlorophenyl)hydroxyarsino]-3-(2,4-dichlorophenoxy)-, As-oxide (8CI)
  • 2-Propanol,1-[(m-chlorophenyl)hydroxyarsino]-3-(2,4-dichlorophenoxy)-, As-oxide (8CI)
  • (2-methoxyphenyl)-phenyl-arsinic acid
  • 4-(6-Methyl-2-{4-[2-methyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl}pyrimidin-4-yl)morpholine
  • N-[1-(3-fluoropyridin-2-yl)piperidin-4-yl]-N-methylpyridin-2-amine
  • N-[1-(3,5-dichloropyridin-2-yl)piperidin-3-yl]-N,5-dimethylpyrimidin-2-amine
  • N-[1-(quinazolin-4-yl)piperidin-3-yl]cyclopropanecarboxamide
  • N-[1-(1-methyl-1H-1,3-benzodiazol-2-yl)piperidin-3-yl]cyclopropanecarboxamide
  • N-methyl-N-{1-[(pyridin-2-yl)methyl]piperidin-4-yl}pyridin-2-amine
  • N-methyl-N-{1-[(pyridin-3-yl)methyl]piperidin-4-yl}pyridin-2-amine
  • N-methyl-N-{1-[(pyridin-4-yl)methyl]piperidin-4-yl}pyridin-2-amine
  • 1-Cyclopropyl-3-{[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl](methyl)amino}-1,2-dihydropyrazin-2-one
  • N-[1-(4,6-dimethoxypyrimidin-2-yl)piperidin-4-yl]-N-methylpyridin-2-amine